Stage IIIB Melanoma

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB17475	Incomplete Freund's adjuvant	0	Completed	1
DB15081	Melanoma antigen recognized by T-cells 1	0	Completed	1
DB06530	Resiquimod	0	Completed	1
DB00041	Aldesleukin	1	Not Yet Recruiting	1
DB05153	Cabozantinib	1	Terminated	1
DB08875	Cabozantinib	1	Terminated	1
DB09110	Coenzyme M	1	Not Yet Recruiting	1
DB00531	Cyclophosphamide	1	Not Yet Recruiting	1
DB01073	Fludarabine	1	Not Yet Recruiting	1
DB17107	Lifileucel	1	Not Yet Recruiting	1
DB09037	Pembrolizumab	1	Not Yet Recruiting	1
DB05238	Vemurafenib	1	Terminated	1
DB08881	Vemurafenib	1	Terminated	1
DB12021	Dinaciclib	1 / 2	Terminated	1
DB15018	Agatolimod	2	Completed	1
DB00041	Aldesleukin	2	Terminated	1
DB06626	Axitinib	2	Completed	1
DB06626	Axitinib	2	Terminated	1
DB11967	Binimetinib	2	Completed	1
DB08912	Dabrafenib	2	Terminated	1
DB01254	Dasatinib	2	Completed	1
DB14800	GP-100 antigen	2	Completed	2
DB00619	Imatinib	2	Completed	1
DB17475	Incomplete Freund's adjuvant	2	Completed	2
DB06186	Ipilimumab	2	Terminated	1
DB11870	RG-4733	2	Withdrawn	1
DB00020	Sargramostim	2	Completed	1
DB11689	Selumetinib	2	Terminated	1
DB08911	Trametinib	2	Completed	1
DB08911	Trametinib	2	Terminated	1
DB16626	Tyrosinase	2	Completed	2
DB01042	Melphalan	Not Available	Withdrawn	1